A recent pilot study to test the feasibility of a 12-week soy-based meal replacement weight loss intervention among ER/PR negative BC survivors showed that an isoflavone rich diet reduced the body weight, total cholesterol and may impact the risk of BC recurrence [206]. This evidence concerns the gene ESR1 and breast cancer.